First National Trust’s GSK GSK Stock Holding History

First National Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,978	Closed	-$221K	–	329
2017 Q4	$221K	Sell	4,978 -1,608	-24%	-$74.3K	0.02%	319
2017 Q3	$335K	Sell	6,586 -1,348	-17%	-$68.4K	0.04%	273
2017 Q2	$428K	Sell	7,934 -161	-2%	-$8.58K	0.05%	238
2017 Q1	$427K	Sell	8,095 -1,785	-18%	-$90.6K	0.06%	239
2016 Q4	$476K	Sell	9,880 -2,650	-21%	-$131K	0.07%	220
2016 Q3	$676K	Sell	12,530 -2,164	-15%	-$119K	0.1%	173
2016 Q2	$796K	Sell	14,694 -2,032	-12%	-$107K	0.12%	158
2016 Q1	$848K	Sell	16,726 -9,697	-37%	-$483K	0.13%	158
2015 Q4	$1.33M	Sell	26,423 -1,468	-5%	-$74.8K	0.21%	134
2015 Q3	$1.34M	Sell	27,891 -532	-2%	-$27.7K	0.23%	124
2015 Q2	$1.48M	Sell	28,423 -4,703	-14%	-$265K	0.24%	123
2015 Q1	$1.91M	Sell	33,126 -15,268	-32%	-$875K	0.33%	88
2014 Q4	$2.58M	Buy	48,394 +17,255	+55%	+$965K	0.46%	71
2014 Q3	$1.79M	Buy	31,139 +27,429	+739%	+$1.68M	0.34%	90
2014 Q2	$248K	Buy	+3,710	New	+$251K	0.05%	225

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

First National Trust's GSK Position: Q1 2018 in Review

First National Trust sold out of GSK (GSK) in Q1 2018, closing a stake of 4,978 shares — an estimated $221K sold.

First National Trust first reported a position in GSK in Q2 2014 and held it in 15 quarters. The position peaked at $2.58M in Q4 2014. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

First National Trust reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
First National Trust sold 4,978 GSK shares in Q1 2018, an estimated $221K.
First National Trust first reported a position in GSK in Q2 2014 and held it in 15 quarters.
First National Trust's GSK position peaked at $2.58M in Q4 2014.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on First National Trust's 13F filing for Q1 2018, filed 30 Apr 2018.